Funding for this research was provided by:
National Key R&D Program of China (2017YFC0113505, 2017YFC0114107)
Received: 26 September 2019
Accepted: 30 June 2020
First Online: 9 July 2020
Ethics approval and consent to participate
: According to the “Ethical Review Measures for Biomedical Research Involving Humans” (2016) issued by the Order of the National Health and Family Planning Commission of the People’s Republic of China (No. 11), biomedical research involving humans includes the following activities: (1) Research activities on human physiology, psychological behavior, pathological phenomena, disease etiology and pathogenesis, and disease prevention, diagnosis, treatment and rehabilitation; (2) Testing and research activities of new medical technologies or new medical products on the human body; (3) The activity of collecting, recording, using, reporting, or storing scientific research materials such as human samples, medical records, and behaviors. This research is eligible for exemption from ethical review, and the need for consent to participate was waived by the Institutional Review Board, Research Management Department in the First Affiliated Hospital, College of Medicine, Zhejiang University.
: The authors declare that they have no conflict of interest.